L. Becker Hewes, Chief Medical Officer at Blueprint Medicines Corp (BPMC), sold 23,466 shares at $101.04 ($2.4M) on 2021-09-15, disclosed to the SEC on 2021-09-17.
Open-market sale of $2.4M BPMC by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.07 | 200 | $20K | 0.8% |
| 2 | $100.05 | 1,734 | $173K | 7.3% |
| 3 | $100.05 | 1,734 | $173K | 7.3% |
| 4 | $101.04 | 5,759 | $582K | 24.5% |
| 5 | $101.04 | 5,759 | $582K | 24.5% |
| 6 | $101.92 | 4,140 |
| $422K |
| 17.8% |
| 7 | $101.92 | 4,140 | $422K | 17.8% |
| Total | $101.19 avg | 23,466 | $2.4M | 100% |
| Filing → |
| BPMC | SELL | 2024-06-04 | $8.3M | — | Filing → |
| BPMC | SELL | 2024-03-11 | $562K | — | Filing → |
| BPMC | SELL | 2023-06-07 | $146K | — | Filing → |